XML 46 R34.htm IDEA: XBRL DOCUMENT v3.7.0.1
Employee Benefit and Deferred Compensation Plans (Tables)
6 Months Ended
Jun. 30, 2017
Retirement Benefits [Abstract]  
Plan expense for non-contributory benefit pension plan and post-retirement health and life plans
The plan expense for the legacy Renasant defined benefit pension plan (“Pension Benefits - Renasant”), the assumed HeritageBank defined pension plan (“Pension Benefits - HeritageBank”) and post-retirement health and life plans (“Other Benefits”) for the periods presented was as follows:
 
Pension Benefits
 
Pension Benefits
 
 
 
Renasant
 
HeritageBank
 
Other Benefits
 
Three Months Ended
 
Three Months Ended
 
Three Months Ended
 
June 30,
 
June 30,
 
June 30,
 
2017
 
2016
 
2017
 
2016
 
2017
 
2016
Service cost
$

 
$

 
$

 
$

 
$
1

 
$
4

Interest cost
291

 
302

 

 
69

 
8

 
15

Expected return on plan assets
(487
)
 
(467
)
 

 
(45
)
 

 

Recognized actuarial loss (gain)
100

 
102

 

 

 
(10
)
 
17

Net periodic benefit (return) cost
$
(96
)
 
$
(63
)
 
$

 
$
24

 
$
(1
)
 
$
36

 
Pension Benefits
 
Pension Benefits
 
 
 
Renasant
 
HeritageBank
 
Other Benefits
 
Six Months Ended
 
Six Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
June 30,
 
2017
 
2016
 
2017
 
2016
 
2017
 
2016
Service cost
$

 
$

 
$

 
$

 
$
4

 
$
8

Interest cost
584

 
608

 

 
138

 
21

 
29

Expected return on plan assets
(971
)
 
(936
)
 

 
(90
)
 

 

Recognized actuarial loss
200

 
202

 

 

 
3

 
34

Net periodic benefit (return) cost
$
(187
)
 
$
(126
)
 
$

 
$
48

 
$
28

 
$
71

Schedule of other share-based compensation activity
The following table summarizes the changes in stock options as of and for the six months ended June 30, 2017:
 
 
Shares
 
Weighted Average Exercise Price
Options outstanding at beginning of period
 
185,625

 
$
15.97

Granted
 

 

Exercised
 
(88,625
)
 
16.14

Forfeited
 

 

Options outstanding at end of period
 
97,000

 
$
15.82

The following table summarizes the changes in restricted stock as of and for the six months ended June 30, 2017:

 
 
Performance-Based Restricted Stock
 
Weighted Average Grant-Date Fair Value
 
Time- Based Restricted Stock
 
Weighted Average Grant-Date Fair Value
Nonvested at beginning of period
 

 
$

 
117,345

 
$
31.76

Awarded
 
54,450

 
42.22

 
99,093

 
42.34

Vested
 

 

 
(40,790
)
 
32.26

Cancelled
 

 

 
(350
)
 
28.93

Nonvested at end of period
 
54,450

 
$
42.22

 
175,298

 
$
37.63